Texas Capital Bancshares Inc/Tx (TCBIO) Revenue (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported Revenue for 17 consecutive years, with $335.5 million the latest figure, recorded in Q2 2026.

• Quarterly Revenue rose 9.12% year-over-year to $335.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.3 billion (up 38.37% YoY) and the FY2025 annual result came in at $1.2 billion, up 31.01% from the prior year.
• Revenue improved to $335.5 million in Q2 2026 per TCBIO's latest filing, from $307.8 million in the prior quarter.
• Over the last five years, Revenue for TCBIO reached as high as $525.3 million in Q4 2022 and fell as low as -$5.6 million in Q3 2023.
• A 5-year average of $224.0 million and a median of $240.1 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue plunged 102.11% — and 2024, when it jumped 2350.92%.
• Year by year, Revenue stood at $525.3 million in 2022, then slumped by 53.2% to $245.8 million in 2023, then decreased by 4.69% to $234.3 million in 2024, then surged by 39.76% to $327.5 million in 2025, then grew by 2.45% to $335.5 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $335.5 million, $307.8 million, and $327.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.